Novel BBS1 deletion and BBS9 nonsense pathogenic variant in Bardet-Biedl syndrome

Janice Min Li,Erika Tavares,Jacque L. Duncan,Ajoy Vincent,Elise Héon
DOI: https://doi.org/10.1080/13816810.2024.2434039
2024-12-04
Ophthalmic Genetics
Abstract:Background Bardet‐Biedl syndrome (BBS) is a rare syndromic ciliopathy characterized with retinal degeneration and a broad range of systemic features. Twenty-six BBS-associated genes have been identified to date and clinical genetic testing resolves around 80% of the cases. Two BBS cases unsolved by clinical genetic testing were recruited to identify causative variants using next-generation sequencing.
ophthalmology,genetics & heredity
What problem does this paper attempt to address?